Application of 3D, 4D, 5D, and 6D bioprinting in cancer research: what does the future look like?

dc.authoridIravani, Siavash/0000-0003-3985-7928
dc.authoridZarrabi, Ali/0000-0003-0391-1769
dc.authorwosidIravani, Siavash/F-4046-2014
dc.authorwosidZarrabi, Ali/U-2602-2019
dc.contributor.authorKhorsandi, Danial
dc.contributor.authorRezayat, Dorsa
dc.contributor.authorSezen, Serap
dc.contributor.authorFerrao, Rafaela
dc.contributor.authorKhosravi, Arezoo
dc.contributor.authorZarepour, Atefeh
dc.contributor.authorKhorsandi, Melika
dc.date.accessioned2024-05-19T14:50:39Z
dc.date.available2024-05-19T14:50:39Z
dc.date.issued2024
dc.departmentİstinye Üniversitesien_US
dc.description.abstractThe application of three- and four-dimensional (3D/4D) printing in cancer research represents a significant advancement in understanding and addressing the complexities of cancer biology. 3D/4D materials provide more physiologically relevant environments compared to traditional two-dimensional models, allowing for a more accurate representation of the tumor microenvironment that enables researchers to study tumor progression, drug responses, and interactions with surrounding tissues under conditions similar to in vivo conditions. The dynamic nature of 4D materials introduces the element of time, allowing for the observation of temporal changes in cancer behavior and response to therapeutic interventions. The use of 3D/4D printing in cancer research holds great promise for advancing our understanding of the disease and improving the translation of preclinical findings to clinical applications. Accordingly, this review aims to briefly discuss 3D and 4D printing and their advantages and limitations in the field of cancer. Moreover, new techniques such as 5D/6D printing and artificial intelligence (AI) are also introduced as methods that could be used to overcome the limitations of 3D/4D printing and opened promising ways for the fast and precise diagnosis and treatment of cancer. Recent advancements pertaining to the application of 3D, 4D, 5D, and 6D bioprinting in cancer research are discussed, focusing on important challenges and future perspectives.en_US
dc.identifier.doi10.1039/d4tb00310a
dc.identifier.issn2050-750X
dc.identifier.issn2050-7518
dc.identifier.pmid38686396en_US
dc.identifier.scopus2-s2.0-85191811462en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org10.1039/d4tb00310a
dc.identifier.urihttps://hdl.handle.net/20.500.12713/5770
dc.identifier.wosWOS:001209568400001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherRoyal Soc Chemistryen_US
dc.relation.ispartofJournal of Materials Chemistry Ben_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240519_kaen_US
dc.subjectArtificial-Intelligenceen_US
dc.subjectNanocomposite Hydrogelen_US
dc.subjectDrug-Deliveryen_US
dc.subjectIn-Vitroen_US
dc.subjectTissueen_US
dc.subjectFabricationen_US
dc.subjectResistanceen_US
dc.subjectScaffoldsen_US
dc.subjectAlginateen_US
dc.subjectImplanten_US
dc.titleApplication of 3D, 4D, 5D, and 6D bioprinting in cancer research: what does the future look like?en_US
dc.typeReview Articleen_US

Dosyalar